Plasma desmosine for prediction of outcomes after acute myocardial infarction
BackgroundElastin degradation is implicated in the pathology of vulnerable plaque. Recent studies show promising results for plasma desmosine (pDES), an elastin-specific degradation product, as a marker of cardiovascular disease (CVD) outcomes. The aim of this study was to investigate the potential...
Main Authors: | Kashan Ali, Muhammad Zubair Israr, Leong L. Ng, Ify Mordi, Chim C. Lang, Elena Kuzmanova, Jeffrey T-J Huang, Anna-Maria Choy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.992388/full |
Similar Items
-
Plasma Desmosine and Abdominal Aortic Aneurysm Disease
by: Ify R. Mordi, et al.
Published: (2019-10-01) -
Desmosine as a biomarker for the emergent properties of pulmonary emphysema
by: Jerome Cantor
Published: (2023-12-01) -
The importance of GRACE score in health care planning of patients after acute myocardial infarction
by: Đorđević Marina, et al.
Published: (2021-01-01) -
Impact of nutritional status on prognosis in acute myocardial infarction patients undergoing percutaneous coronary intervention
by: Daisuke Kanda, et al.
Published: (2022-01-01) -
External validation of the GRACE risk score in patients with myocardial infarction in Hungary
by: Tamás Ferenci, et al.
Published: (2023-06-01)